BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10779990)

  • 1. Male gonadal function in survivors of childhood Hodgkin and non-Hodgkin lymphoma.
    Ben Arush MW; Solt I; Lightman A; Linn S; Kuten A
    Pediatr Hematol Oncol; 2000; 17(3):239-45. PubMed ID: 10779990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease.
    van den Berg H; Furstner F; van den Bos C; Behrendt H
    Pediatr Blood Cancer; 2004 Mar; 42(3):210-5. PubMed ID: 14752856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens.
    Paoli D; Rizzo F; Fiore G; Pallotti F; Pulsoni A; Annechini G; Lombardo F; Lenzi A; Gandini L
    Hum Reprod; 2016 Feb; 31(2):263-72. PubMed ID: 26705149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadal function following ABVD therapy for Hodgkin's disease.
    Kulkarni SS; Sastry PS; Saikia TK; Parikh PM; Gopal R; Advani SH
    Am J Clin Oncol; 1997 Aug; 20(4):354-7. PubMed ID: 9256888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadal function and fertility in male survivors treated for Hodgkin's disease in Iran.
    Rafsanjani KA; Faranoush M; Hedayatiasl AA; Vossough P
    Saudi Med J; 2007 Nov; 28(11):1690-3. PubMed ID: 17965791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Hodgkin's disease in children with alternating mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy.
    van den Berg H; Stuve W; Behrendt H
    Med Pediatr Oncol; 1997 Jul; 29(1):23-7. PubMed ID: 9142201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Semen preservation and gonadal toxicity in the treatment of non Hodgkin lymphoma. Experience at the Gustave-Roussy Institute from 1980 to 1993].
    Naccache P; Decaudin D; Koscielny S; Bendahmane B; Auger J; Munck JN
    Bull Cancer; 1996 Apr; 83(4):307-14. PubMed ID: 8680082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials.
    Behringer K; Mueller H; Goergen H; Thielen I; Eibl AD; Stumpf V; Wessels C; Wiehlpütz M; Rosenbrock J; Halbsguth T; Reiners KS; Schober T; Renno JH; von Wolff M; van der Ven K; Kuehr M; Fuchs M; Diehl V; Engert A; Borchmann P
    J Clin Oncol; 2013 Jan; 31(2):231-9. PubMed ID: 23150709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
    Canellos GP
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD.
    Viviani S; Santoro A; Ragni G; Bonfante V; Bestetti O; Bonadonna G
    Eur J Cancer Clin Oncol; 1985 May; 21(5):601-5. PubMed ID: 2408897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of psychosocial adaptation and sexual function of survivors of advanced Hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVD.
    Kornblith AB; Anderson J; Cella DF; Tross S; Zuckerman E; Cherin E; Henderson ES; Canellos GP; Kosty MP; Cooper MR
    Cancer; 1992 Nov; 70(10):2508-16. PubMed ID: 1384949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density, growth, and thyroid function in long-term survivors of pediatric Hodgkin's lymphoma treated with chemotherapy only.
    van Beek RD; van den Heuvel-Eibrink MM; Hakvoort-Cammel FG; van den Bos C; van der Pal HJ; Krenning EP; de Rijke YB; Pieters R; de Muinck Keizer-Schrama SM
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1904-9. PubMed ID: 19293271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up of sperm concentration and motility in patients with lymphoma.
    Tal R; Botchan A; Hauser R; Yogev L; Paz G; Yavetz H
    Hum Reprod; 2000 Sep; 15(9):1985-8. PubMed ID: 10967000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation.
    Delwail V; Jais JP; Colonna P; Andrieu JM
    Br J Haematol; 2002 Jul; 118(1):189-94. PubMed ID: 12100147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology.
    Oberlin O; Leverger G; Pacquement H; Raquin MA; Chompret A; Habrand JL; Terrier-Lacombe MJ; Bey P; Bertrand Y; Rubie H
    J Clin Oncol; 1992 Oct; 10(10):1602-8. PubMed ID: 1383434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of lymphoma treatments on spermatogenesis and sperm deoxyribonucleic acid: a multicenter prospective study from the CECOS network.
    Bujan L; Walschaerts M; Brugnon F; Daudin M; Berthaut I; Auger J; Saias J; Szerman E; Moinard N; Rives N; Hennebicq S
    Fertil Steril; 2014 Sep; 102(3):667-674.e3. PubMed ID: 25044088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative effect of combined chemotherapy and fractionated radiotherapy on the incidence of radiation-induced lung damage: a prospective clinical study.
    Mah K; Keane TJ; Van Dyk J; Braban LE; Poon PY; Hao Y
    Int J Radiat Oncol Biol Phys; 1994 Feb; 28(3):563-74. PubMed ID: 7509329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should MOPP-ABVD alone be standard for childhood Hodgkin's?
    Constine LS
    J Clin Oncol; 1998 Mar; 16(3):1235. PubMed ID: 9508214
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.
    Comella P; Abate G; Fiore M; Di Finizio G; Frezza P; Scoppa G; Anania C; Coucourde F; Zarrilli D
    J Chemother; 1989 Jul; 1(4 Suppl):1254-6. PubMed ID: 16312855
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
    Weiner MA; Leventhal B; Brecher ML; Marcus RB; Cantor A; Gieser PW; Ternberg JL; Behm FG; Wharam MD; Chauvenet AR
    J Clin Oncol; 1997 Aug; 15(8):2769-79. PubMed ID: 9256118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.